Viimeisimmät kokeilut

EudraCT Number: 2004-002844-93 Sponsor Protocol Number: 6002-INT-001 Start Date: 2005-02-08
Sponsor Name: Kyowa Hakko U.K. Limited
Full Title: A Long-Term, Multicenter, Open-Label Safety Study with Oral 20 or 40 mg/d Doses of KW-6002 (Istradefylline) as Treatment for Parkinson’s Disease in Patients with Motor Response Complications on Lev...
Medical condition: Parkinson's Disease
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) LV (Completed) GB (Completed) EE (Completed) AT (Completed) IT (Completed) ES (Completed)
Trial results: (No results available)
EudraCT Number: 2004-001021-22 Sponsor Protocol Number: NKO101287 Start Date: 2005-02-08
Sponsor Name: GlaxoSmithKline Research and Development Limited
Full Title: A Multicentre, Randomised, Double-blind, Double-dummy, Placebo-controlled, Parallel Group, Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Oral (25 mg) and Intravenous (3 m...
Medical condition: Post Operative Nausea and Vomiting (PONV) Post Discharge Nausea and Vomiting (PDNV)
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults Gender: Female
Trial protocol: FI (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2004-004329-90 Sponsor Protocol Number: OGTT Version 3. 18.05.07 Start Date: 2005-02-08
Sponsor Name: CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST
Full Title: EARLY METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY FOR ESSENTIAL HYPERTENSION (MAIN STUDY).
Medical condition: ESSENTIAL HYPERTENSION
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
EudraCT Number: 2004-000905-24 Sponsor Protocol Number: 25052004 Start Date: 2005-02-08
Sponsor Name: University of York
Full Title: Cryotherapy versus salicylic acid for the treatment of verrucae: a randomised controlled trial.
Medical condition: Verrucae
Disease: Version SOC Term Classification Code Term Level
Population Age: Adolescents, Under 18, Adults, Elderly Gender: Male, Female
Trial protocol: GB (Completed) IE (Completed)
Trial results: View results
EudraCT Number: 2004-003880-61 Sponsor Protocol Number: 060-CL-305 Start Date: 2005-02-08
Sponsor Name: Yamanouchi Europe B.V.
Full Title: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE POTENTIAL EFFICACY, SAFETY AND TOLERABILITY OF DIFFERENT ORAL DOSES OF YM060 IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE ...
Medical condition: diarrhea-predominant irritable bowel syndrome
Disease: Version SOC Term Classification Code Term Level
10023003
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: LT (Completed) EE (Completed) CZ (Completed)
Trial results: View results
EudraCT Number: 2005-000778-31 Sponsor Protocol Number: n3-PUFA-HF/1 Start Date: 2005-02-08
Sponsor Name: Dept. of Cardiology, Medical University of Vienna
Full Title: OMEGA-3-POLYUNSATURATED FATTY-ACIDS (n3-PUFA) IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE: EFFECTS ON ENDOTHELIAL FUNCTION, LEFT VENTRICULAR REMODELLING, NATRIURETIC PEPTIDE LEVELS, AND EXERCISE ...
Medical condition: chronic heart failure
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: AT (Ongoing)
Trial results: (No results available)
EudraCT Number: 2004-003255-39 Sponsor Protocol Number: MCL2004FI Start Date: 2005-02-08
Sponsor Name: The Finnish Lymphoma group
Full Title: Treatment protocol for elderly patients with mantle cell lymphoma (MCL). A phase II study of the Finnish Lymphoma Group.
Medical condition: Mantle cell lymphoma
Disease: Version SOC Term Classification Code Term Level
Population Age: Elderly Gender: Male, Female
Trial protocol: FI (Completed)
Trial results: (No results available)
EudraCT Number: 2005-000170-40 Sponsor Protocol Number: EPC/01 Start Date: 2005-02-07
Sponsor Name: OSPEDALE S. RAFFAELE
Full Title: EFFECT OF AN ORAL DOSE OF FERROUS SULFATE ON URINARY ESCRETION OF EPCIDINA IN PATIENTS AFFECTED BY EMOCROMATOSI.
Medical condition: TREATMENT OF EMOCROMATOSIS
Disease: Version SOC Term Classification Code Term Level
6.1 10005329 SOC
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results
EudraCT Number: 2004-002694-22 Sponsor Protocol Number: R092670PSY3002 Start Date: 2005-02-07
Sponsor Name: Janssen-Cilag International N.V
Full Title: A Randomized, Double-Blind, Parallel Group Non-inferiority Study of Flexibly Dosed Paliperidone Palmitate(25, 50, 75, 100 mg eq) Administered Every 4 weeks and Flexibly Dosed Risperdal Consta (25, ...
Medical condition: schizophrenia
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: HU (Completed) AT (Completed) SE (Completed) CZ (Completed) DK (Completed) EE (Completed) ES (Completed) LT (Completed)
Trial results: View results
EudraCT Number: 2004-003745-40 Sponsor Protocol Number: GS-IT-131-0151 Start Date: 2005-02-07
Sponsor Name: GILEAD SCIENCES S.R.L.
Full Title: Phase II pilot study on safety of administration of 3mg/kg/day three times a week until day 22 (21 days after transplantation day) and 7 mg/kg weekly from day 29 to the end of treatment ( day 50-8t...
Medical condition: Fungal Infection High risk patients undergoing allogeneic stem-cell transplantation.
Disease: Version SOC Term Classification Code Term Level
14.1 10021881 - Infections and infestations 10017528 Fungal infectious disorders HLGT
Population Age: Adults Gender: Male, Female
Trial protocol: IT (Completed)
Trial results: View results

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa